Related Experiment Video
Updated: May 20, 2026

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
Published on: December 2, 2015
Demographic and co-morbid predictors of stress (takotsubo) cardiomyopathy
Abdulrahman M El-Sayed1, Waleed Brinjikji, Samer Salka
1Department of Epidemiology, Columbia University, New York, New York, USA. ame2145@columbia.edu
Insights
Stress cardiomyopathy (SC) disproportionately affects women and differs from heart attacks (MI) in patient demographics and co-morbidities. Understanding these predictors aids in diagnosing SC, which may involve elevated catecholamines.
Area of Science:
- Cardiology
- Epidemiology
- Internal Medicine
Background:
- Epidemiology of stress (takotsubo) cardiomyopathy (SC) is not well understood.
- Identifying demographic and co-morbid predictors is crucial for understanding SC.
- Comparing SC predictors to myocardial infarction (MI) and orthopedic controls can elucidate unique characteristics.
Purpose of the Study:
- To characterize population-level predictors of stress (takotsubo) cardiomyopathy (SC).
- To compare demographic and co-morbid differences and similarities between SC and myocardial infarction (MI).
- To identify potential mechanisms, such as catecholamine influence, in SC development.
Main Methods:
- A 3-arm case-control study design was employed.
- Data from 24,701 patients diagnosed with SC (2008-2009 National Inpatient Samples) were analyzed.
- SC cases were compared to age-matched controls with MI and orthopedic injuries using McNemar tests.
Main Results:
- SC predominantly affected women (89.0%) compared to MI (38.9%) and orthopedic controls (55.7%).
- SC patients were more likely to be white, from wealthier areas, and less likely to have traditional cardiovascular risk factors.
- SC patients had higher rates of cerebrovascular accidents, drug abuse, mood disorders, malignancy, chronic liver disease, and sepsis.
Conclusions:
- Demographic and co-morbid predictors of SC significantly differ from those of MI.
- These distinct predictors are valuable for clinical diagnosis of SC.
- Identified co-morbidities may influence SC through elevated catecholamine levels.
Abstract:
Little is known about the epidemiology of stress (takotsubo) cardiomyopathy (SC). We used a 3-arm case-control study to assess differences in demographic and co-morbid predictors of SC compared to orthopedic controls and myocardial infarction (MI) controls to characterize (1) population-level predictors of SC generally and (2) differences and similarities in determinants of SC compared to MI. We included data on all discharges of patients diagnosed with SC from the 2008 to 2009 National Inpatient Samples and randomly selected 1-to-1 age-matched controls from patients hospitalized with MI and patients hospitalized with joint injuries after trauma. We used McNemar tests to assess differences in demographic characteristics and co-morbidities between patients with SC and controls. There were 24,701 patients with SC in our study. Of patients with SC, 89.0% were women compared to 38.9% of patients with MI and 55.7% of orthopedic controls. Patients with SC were more likely to be white and to reside in wealthier ZIP codes compared to MI and orthopedic controls. Patients with SC were less likely to have cardiovascular risk factors compared to MI and orthopedic controls but were more likely to have had histories of cerebrovascular accidents, drug abuse, anxiety disorders, mood disorders, malignancy, chronic liver disease, and sepsis. In conclusion, demographic and co-morbid predictors of SC differ substantially from those of MI and may be of interest to providers when diagnosing SC. Several co-morbid risk factors predictive of SC may operate by increased catecholamines.
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease I: Introduction
Cardiomyopathy I: Introduction and Classification
Acute Coronary Syndrome III: Diagnostic Studies
Cardiomyopathy II: Dilated Cardiomyopathy
Introduction to Stress and Lifestyle